ProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual Meeting
24 avr. 2023 07h30 HE
|
ProMIS Neurosciences Inc.
Lead therapeutic candidate for Alzheimer’s disease, PMN310, demonstrated selective binding and protection against toxic amyloid-beta oligomersPreclinical data support misfolded RACK1 as a potential...
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease
05 avr. 2023 07h00 HE
|
AC Immune SA
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease Webinar to take place on Tuesday, April 18, 2023, at 10:30 AM EDT / 4:30 PM CEST Lausanne,...
Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases
13 févr. 2023 04h00 HE
|
Astex Pharmaceuticals
CAMBRIDGE and CARDIFF, United Kingdom, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small...
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43
07 févr. 2023 07h00 HE
|
AC Immune SA
AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 The Michael J. Fox Foundation grant supports the development of AC Immune’s first-in-class TDP-43 PET tracer...
Zhittya Genesis Medicine - Parkinson’s Disease and Other Brain Disorders: Is FGF-1 a Novel Breakthrough Medical Treatment
25 oct. 2022 10h00 HE
|
Zhittya Genesis Medicine Inc
Invitation to a Free Luncheon Presentation in Jeddah, Saudi Arabia, on Monday, October 31, 2022, at 1:00 pm (13:00) View Preliminary Human Data after 30 Days Treatment of Parkinson’s Disease Patients...
With 7.2% CAGR, Neurodegenerative Diseases Drugs Market Size to Surpass Around USD 62,786.2 Million by 2028
29 juin 2022 04h30 HE
|
Fortune Business Insights
Pune, India, June 29, 2022 (GLOBE NEWSWIRE) -- The global neurodegenerative diseases drugs market is likely to gain traction from the rising incidence of neurodegenerative diseases worldwide. Such...
Zhittya Genesis Medicine announces: Free Zoom Webinar: Parkinson’s Disease Sufferers Motor Skills Improve by 50% After Medical Research Study
21 juin 2022 10h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 21, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that they will be hosting a webinar on June 23, 2022 at 3:00 PM Pacific Time...
Zhittya Genesis Medicine Announces: Parkinson’s Disease Sufferers Motor Skills Improved by 50% After Medical Research Study
16 juin 2022 14h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 16, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that the human test subjects in its first-in-human research study for the...
Global Autologous Cell Therapy Product Market ($ 34.8 Bn by 2028) Growth Forecast at 17.1% CAGR During 2022 to 2028 COVID-19 Impact and Global Analysis by Vantage Market Research
04 mars 2022 03h40 HE
|
Vantage Market Research
WASHINGTON, March 04, 2022 (GLOBE NEWSWIRE) -- Recently, the Autologous Cell Therapy Product Market is changing the face of the medicinal treatment and therapeutics. The major factors driving the...
Sunshine Biopharma Expands Board of Directors
03 nov. 2021 12h35 HE
|
Sunshine Biopharma Inc.
MONTREAL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...